<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Doxycycline - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Doxycycline</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Doxycycline</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Doxycycline 100mg Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Chlamydia (uncomplicated, non-pregnant adults)</strong>
            <ul>
              <li>100 mg PO twice daily for 7 days</li>
            </ul>
          </li>
          <li><strong>Skin/soft tissue infection</strong> (selected cases; follow local guidance for organism risk)
            <ul>
              <li>100 mg PO twice daily (typical duration 5–10 days depending on severity/response)</li>
            </ul>
          </li>
          <li><strong>Community-acquired pneumonia</strong> (selected outpatient cases; follow local guidance)
            <ul>
              <li>100 mg PO twice daily (typical duration ~5–7 days depending on severity/response)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Susceptible bacterial infections where doxycycline is appropriate (respiratory, skin/soft tissue, some STIs)</li>
          <li>Chlamydia treatment (first-line in non-pregnant adults)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Contraindicated in tetracycline hypersensitivity</li>
          <li>Avoid in pregnancy (especially 2nd/3rd trimester) and generally avoid during breastfeeding unless directed (tooth/bone effects)</li>
          <li>Avoid in children &lt;8 years unless specialist-directed (tooth discoloration/bone effects)</li>
          <li>Esophagitis/esophageal ulcer risk: take with plenty of water; remain upright after dose</li>
          <li>Photosensitivity risk (sunburn): counsel on sun protection</li>
          <li>Drug/food interactions that reduce absorption:
            <ul>
              <li>Separate from iron, calcium, magnesium, aluminum antacids, bismuth, zinc, and multivitamins (separate by at least 2–3 hours)</li>
            </ul>
          </li>
          <li>Interaction cautions: warfarin (INR effects), isotretinoin (intracranial hypertension risk)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>GI upset (nausea, diarrhea), pill esophagitis</li>
          <li>Photosensitivity rash/sunburn</li>
          <li>Vaginal/oral candidiasis</li>
          <li>Rare/serious: hepatotoxicity, severe rash, intracranial hypertension</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO tablets: give with a full glass of water</li>
          <li>Take sitting/standing; avoid lying down for at least 30 minutes after dose</li>
          <li>May take with food to reduce GI upset (avoid taking with dairy/antacids/minerals at the same time)</li>
          <li>Separate from iron/calcium/magnesium/aluminum/zinc products by at least 2–3 hours</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Clinical response (fever/pain/lesion improvement) within expected timeframe</li>
          <li>GI tolerance; counsel to report severe/persistent diarrhea</li>
          <li>If prolonged therapy or significant comorbidity: consider LFTs per clinician judgment</li>
          <li>If on warfarin: consider INR monitoring per clinician judgment</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Sun exposure at sea can be significant: reinforce sun protection and photosensitivity precautions</li>
          <li>Simplify dosing schedule (BID) and document start/stop dates clearly to support adherence</li>
          <li>Flag "separate from minerals/antacids" because shipboard patients often take supplements</li>
          <li>If pregnancy is possible: screen before use and preferentially use alternatives where indicated</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li><a href="https://pdf.hres.ca/dpd_pm/00042215.PDF" target="_blank" rel="noopener">Health Canada product monograph (doxycycline 100 mg)</a></li>
          <li><a href="https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/chlamydia-lgv/treatment-follow-up.html" target="_blank" rel="noopener">PHAC Chlamydia treatment guidance</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
